PBP logo

Probiotec Limited Stock Price

ASX:PBP Community·AU$242.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

PBP Share Price Performance

AU$0
0.00 (0.00%)
AU$0
0.00 (0.00%)
Price AU$0

PBP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

1 Risk
2 Rewards

Probiotec Limited Key Details

AU$221.2m

Revenue

AU$155.0m

Cost of Revenue

AU$66.3m

Gross Profit

AU$57.6m

Other Expenses

AU$8.7m

Earnings

Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
0.11
29.95%
3.93%
52.5%
View Full Analysis

About PBP

Founded
1996
Employees
n/a
CEO
Wesley Stringer
WebsiteView website
www.probiotec.com.au

Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia.

Recent PBP News & Updates

Recent updates

No updates